The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed

NCT00534677 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Portal Hypertension
Cirrhosis
Hematemesis
Melena

Interventions

DRUG: Terlipressin
DRUG: Octreotide

Sponsor

Aga Khan University